Conservative management options for morbidly adherent placenta

Authors

  • Meena N. Satia Department of Obstetrics and Gynecology, Seth Gordhandas Sunderdas Medical College and King Edward VII Memorial Hospital, Mumbai, Maharashtra, India
  • Animesh Gandhi Department of Obstetrics and Gynecology, Seth Gordhandas Sunderdas Medical College and King Edward VII Memorial Hospital, Mumbai, Maharashtra, India
  • Manali P. Shilotri Department of Obstetrics and Gynecology, Seth Gordhandas Sunderdas Medical College and King Edward VII Memorial Hospital, Mumbai, Maharashtra, India

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20170584

Keywords:

Adherent placenta, Internal iliac artery balloon placement, Methotrexate, Obstetric hysterectomy

Abstract

Background: Morbidly adherent placenta is still a very significant cause of obstetric hemorrhage.

Methods: A retrospective, descriptive study was undertaken over a period of one and a half year in a tertiary care hospital of all diagnosed cases of morbidly adherent placenta which were managed conservatively and the maternal and perinatal outcomes were noted. Preparation for conservative management of cases of adherent placenta in the antenatal period included informing interventional radiologists and placement of internal iliac balloon catheters just before classical caesarean section. Post-operative methotrexate was used in a few patients.

Results: 11 cases of morbidly adherent placenta diagnosed on Doppler ultrasound scan, and confirmed by MRI were identified. All patients underwent classical caesarean section. 9 patients had internal iliac balloon placement. 5 patients received methotrexate. 3 patients required obstetric hysterectomy. 1 maternal and 2 perinatal mortalities were noted.

Conclusions: Interventional radiology and methotrexate can be used to avoid peripartum hysterectomy and to optimize maternal and perinatal outcome.

Author Biographies

Meena N. Satia, Department of Obstetrics and Gynecology, Seth Gordhandas Sunderdas Medical College and King Edward VII Memorial Hospital, Mumbai, Maharashtra, India

Professor and Head of Unit, Department of Obstetrics and Gynaecology.

Animesh Gandhi, Department of Obstetrics and Gynecology, Seth Gordhandas Sunderdas Medical College and King Edward VII Memorial Hospital, Mumbai, Maharashtra, India

Assistant Professor, Department of Obstetrics and Gynaecology.

Manali P. Shilotri, Department of Obstetrics and Gynecology, Seth Gordhandas Sunderdas Medical College and King Edward VII Memorial Hospital, Mumbai, Maharashtra, India

Third Year Post-graduate student, Department of Obstetrics and Gynaecology.

References

Cunningham FG, Leveno KJ, Bloom SL, Hauth, Rouse, Spong CY (eds.). Williams Obstetrics. 23rd edition. The United States of America: The McGraw- Hill Education; 2010.

Sonin A. Nonoperative treatment of placenta percreta: value of MR imaging. AJR Am J Roentgenol. 2001;177(6):1301-3.

Miller DA, Chollet JA, Goodwin TM. Clinical risk factors for placenta previa-placenta accrete. Am J Obstet Gynecol. 1997;177:210-4.

Umezurike CC, Nkwocha G. Placenta accrete in Aba, south eastern, Nigeria. Niger J Med. 2007;16(3):219-22.

Wu S, Kocherginsky M, Hibbard JU. Abnormal placentation: Twenty-year analysis. Am J Obstet Gynecol. 2005;192:1458.

Alkazaleh F, Geary M, Kingdom J, Kachura JR, Windrim R. Elective non-removal of the placenta and prophylactic uterine artery embolization postpartum as a diagnostic imaging approach for the management of placenta percreta: a case report. J Obstet Gynaecol Can. 2004;26:743-6.

Kayem G, Davy C, Goffinet F, Thomas C, Clement D, Cabrol D. Conservative versus extirpative management in cases of placenta accreta. Obstet Gynecol. 2004;104:531-6.

Butt K, Gagnon A, Delisle MF. Failure of methotrexate and internal iliac balloon catheterization to manage placenta percreta. Obstet Gynecol. 2002;99:981-2.

Downloads

Published

2017-02-19

Issue

Section

Original Research Articles